<DOC>
	<DOCNO>NCT01394770</DOCNO>
	<brief_summary>Hypertensive haemodialysis patient high risk cardiovascular event . This study undertaken ascertain whether aliskiren , direct renin inhibitor , compare amlodipine , calcium channel blocker , reduce mortality cardiovascular event high-risk patient .</brief_summary>
	<brief_title>Aliskiren Amlodipine Hypertensive Hemodialysed Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>hemodialysed patient predialytic blood pressure great equal 140/90 mmHg history heart failure history ischemic heart disease severe aortic stenosis know allergy aliskiren amlodipine severe disorder liver function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>dialysis</keyword>
	<keyword>aliskiren</keyword>
	<keyword>amlodipine</keyword>
	<keyword>outcome</keyword>
</DOC>